1. Neurological Disease

Neurological Disease

A range of neurological disorders, including epilepsy and dystonia, may involve dysfunctional intracortical inhibition, and may respond to treatments that modify it. Parkinson’s is a neurodegenerative disease characterized by increased activity of GABA in basal ganglia and the loss of dopamine in nigrostriatum, associated with rigidity, resting tremor, gait with accelerating steps, and fixed inexpressive face. Neurological deficits, along with neuromuscular involvement, are characteristic of mitochondrial disease, and these symptoms can have a dramatic impact on patient quality of life. Neurological features may be manifold, ranging from neural deafness, ataxia, peripheral neuropathy, migraine, seizures, stroke‐like episodes and dementia and depend on the part of the nervous system affected.

Neurological Disease Related Products (1404):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-17366
    Clozapine N-oxide 34233-69-7 99.63%
    Clozapine N-oxide is a pharmacologically inert metabolite of Clozapine, which is a potent 5-HT1C receptor antagonist. Clozapine N-oxide (CNO) is a DREADD (designer receptors exclusively activated by designer drug) agonist.
    Clozapine N-oxide
  • HY-13027
    DAPT 208255-80-5 99.25%
    DAPT is a γ-secretase inhibitor, reduces the total beta-amyloid peptide () production with IC50 of 20 nM in HEK 293 cells.
    DAPT
  • HY-15608
    MPTP hydrochloride 23007-85-4 99.16%
    MPTP (hydrochloride) is a prodrug to the neurotoxin MPP which causes permanent symptoms of Parkinson's disease.
    MPTP hydrochloride
  • HY-B0215
    Acetylcysteine 616-91-1 >98.0%
    Acetylcysteine is used mainly as a mucolytic, which protects against acetaminophen overdose-induced hepatotoxicity by maintaining or restoring hepatic concentrations of glutathione.
    Acetylcysteine
  • HY-B1756
    Rotenone 83-79-4 >98.0%
    Rotenone is an inhibitor of mitochondrial electron transport at NADH:ubiquinone oxidoreductase, and is used to induce a Parkinson-like syndrome as an experimental model in rats.
    Rotenone
  • HY-12526
    Tetrodotoxin 4368-28-9 99.99%
    Tetrodotoxin is a highly selective sodium channel blocker, with IC50 of 33 nM for Nav1.6.
    Tetrodotoxin
  • HY-B0726
    Pilocarpine Hydrochloride 54-71-7 99.92%
    Pilocarpine Hydrochloride is a selective M3-type muscarinic acetylcholine receptor (M3 muscarinic receptor) agonist.
    Pilocarpine Hydrochloride
  • HY-15084
    (+)-MK 801 Maleate 77086-22-7 99.98%
    (+)-MK 801 (Maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes.
    (+)-MK 801 Maleate
  • HY-B0075
    Melatonin 73-31-4 >98.0%
    Melatonin, a hormone produced in the brain, is a potent melatonin receptor activator, and possesses important antioxidative and anti-inflammatory properties.
    Melatonin
  • HY-100229
    Aloxistatin 88321-09-9 98.22%
    Aloxistatin (E64d) is a broad-spectrum cell-permeable cysteine protease inhibitor.
    Aloxistatin
  • HY-B0617
    Ademetionine 29908-03-0 >98.0%
    Ademetionine(S-adenosyl-l-methionine; SAMe) is a naturally-occurring substance which is a major source of methyl groups in the brain.
    Ademetionine
  • HY-B0150
    Nicotinamide 98-92-0 >98.0%
    Nicotinamide is a water-soluble vitamin, an active component of coenzymes NAD and NADP, and acts as poly (ADP-ribose) polymerase (PARP) inhibitor.
    Nicotinamide
  • HY-13291
    WIN 55,212-2 Mesylate 131543-23-2 98.98%
    WIN 55,212-2 (Mesylate) is a potent aminoalkylindole cannabinoid (CB) receptor agonist with Kis of 62.3 and 3.3 nM for human recombinant CB1 and CB2 receptors, respectively.
    WIN 55,212-2 Mesylate
  • HY-B0407A
    Chlorpromazine hydrochloride 69-09-0 99.83%
    Chlorpromazine Hydrochloride is an antagonist of the dopamine D2 receptors, 5-HT2A receptors, potassium channel, sodium channel, with Ki of 363 nM and 8.3 nM for dopamine D2 receptor and serotonin 5-HT2A receptor, respectively.
    Chlorpromazine hydrochloride
  • HY-16759
    Verubecestat 1286770-55-5 99.79%
    MK-8931 is a BACE1 inhibitor. MK-8931 binds significantly to β-secretase.
    Verubecestat
  • HY-10095
    Olcegepant 204697-65-4 99.32%
    Olcegepant is the first potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and with a Ki of 14.4 pM for human CGRP.
    Olcegepant
  • HY-10052
    Aprepitant 170729-80-3 98.33%
    Aprepitant is a specific NK-1R antagonist, used as an antiemetic agent.
    Aprepitant
  • HY-19370
    FPS-ZM1 945714-67-0 99.31%
    FPS-ZM1 is a high-affinity RAGE specific inhibitor with a Ki of 25 nM.
    FPS-ZM1
  • HY-12012
    SB 216763 280744-09-4
    SB 216763 is potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor, with IC50 value of 34.3 nM for GSK-3α and GSK-3β, respectively.
    SB 216763
  • HY-16900
    Rolipram 61413-54-5 99.56%
    Rolipram is a selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively.
    Rolipram